Study design | Selective, opportunistic cross-sectional study from 20 pharmacies in the Perth metropolitan region |
Eligibility criteria | Asymptomatic women ≥18 years requesting EC |
Specimen type and collection method | Self-collected low-vaginal collection swab taken either at home or at a designated pathology laboratory |
Options for returning specimen for analysis | Either at one of the designated pathology laboratories or at the primary issuing pharmacy |
Pathology laboratory procedure | Nucleic acid amplification tests utilising target capture, transcription-mediated amplification and hybridisation protection assay |
Dissemination of chlamydia test results to consumers | Designated free-phone number that women called 72 h after returning their specimen. Results handled by a chlamydia screening officer based at Sexual Health Services, Fremantle Hospital |
Treatment for chlamydia positive women and sexual partner notification | Handled by a sexual health physician based at Sexual Health Services, Fremantle Hospital |